Conversations

How can we better utilize public-private partnerships to advance translation of science into new medicines for some of our most challenging diseases, such as neurological disorders?

Contributors Respond

Adam Gilden Tsai
,


Conversations

What are the biggest challenges and opportunities when it comes to improving patient health?

Contributors Respond

Crawford Clay
,


Karen Kerrigan
,


Steven P. Caltrider
,


Jay Taylor
,


Mark Elliot
,


Conversations

What steps should the U.S. take to protect and strengthen IP rights domestically and overseas?

Contributors Respond

Randy Beranek
,


Pages

Subscribe to PhRMA RSS